Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05295615 · ClinicalTrials.gov registry record · NA

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by Herrick Medical.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05295615 is a NA study of Alzheimer Disease that is actively recruiting participants, run by Herrick Medical. The registered enrollment target is 40 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05295615, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by Herrick Medical.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.

Conditions Studied

Alzheimer Disease

Interventions

  • DEVICE ECHS AD Device

Study Locations (1)

New Jersey

  • Hackensack Medical Center - Hackensack

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-05-01
Est. Completion 2026-09-30
Phase NA

Sponsor

Herrick Medical

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05295615

The ClinicalTrials.gov registry entry for NCT05295615 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Herrick Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which ECHS AD Device is the first listed.

NCT05295615 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05295615 about?

NCT05295615 is a clinical study titled "Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease". An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. ...

What is the current status of trial NCT05295615?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-01. Estimated completion is 2026-09-30.

What conditions does trial NCT05295615 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05295615?

The interventions under investigation include: ECHS AD Device (DEVICE).

Who is sponsoring clinical trial NCT05295615?

This trial is sponsored by Herrick Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05295615 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.